CVS Health (CVS) PT Raised to $76 at Truist Securities
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- S&P 500, Nasdaq rise as tech stocks gain ahead of midterm results
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mailGet Alerts CVS Hot Sheet
Price: $90.16 +1.86%
Rating Summary:
34 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 16 | New: 12
Rating Summary:
34 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 16 | New: 12
Join SI Premium – FREE
Truist Securities analyst David MacDonald raised the price target on CVS Health (NYSE: CVS) to $76.00 (from $66.00) while maintaining a Buy rating.
You May Also Be Interested In
- CVS Health (CVS) call put ratio 1.1 calls to 1 put into quarter results
- ACI Worldwide (ACIW) PT Raised to $72 at DA Davidson
- Avita Medical Ltd. (RCEL) PT Raised to $20 at TD Cowen
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
